Bioqual is selling at 37.51 as of the 12th of February 2026; that is 0.5 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 37.51. Bioqual has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 14th of November 2025 and ending today, the 12th of February 2026. Click here to learn more.
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland. Bioqual operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.. The company has 896 K outstanding shares. More on Bioqual
Bioqual [BIOQ] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 73.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioqual's market, we take the total number of its shares issued and multiply it by Bioqual's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bioqual conducts business under Biotechnology sector and is part of Health Care industry. The entity has 896 K outstanding shares.
Bioqual currently holds about 2.18 M in cash with 313.36 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.44.
Check Bioqual Probability Of Bankruptcy
The company recorded earning per share (EPS) of 6.15. Bioqual last dividend was issued on the 5th of October 2022. The entity had 1:6 split on the 28th of October 1997. Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland. Bioqual operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.The quote for Bioqual is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bioqual please contact Mark Lewis at 240 404 7654 or go to https://www.bioqual.com.
Bioqual Investment Alerts
Bioqual generated a negative expected return over the last 90 days
Bioqual Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 73.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioqual's market, we take the total number of its shares issued and multiply it by Bioqual's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Bioqual Profitablity
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1.
Technical Drivers
As of the 12th of February 2026, Bioqual shows the Standard Deviation of 0.5239, risk adjusted performance of (0.15), and Mean Deviation of 0.1824. Bioqual technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
The output start index for this execution was zero with a total number of output elements of sixty-one. Bioqual Tanh Of Price Series is a hyperbolic price transformation function.
Bioqual Outstanding Bonds
Bioqual issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bioqual uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bioqual bonds can be classified according to their maturity, which is the date when Bioqual has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Bioqual intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bioqual pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Bioqual's time-series forecasting models are one of many Bioqual's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bioqual's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Bioqual without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio Comparator Now
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
When running Bioqual's price analysis, check to measure Bioqual's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioqual is operating at the current time. Most of Bioqual's value examination focuses on studying past and present price action to predict the probability of Bioqual's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioqual's price. Additionally, you may evaluate how the addition of Bioqual to your portfolios can decrease your overall portfolio volatility.